| 英文名稱 | SP600125 (Synonyms: Nsc75890; SP 600125; Anthra[1,9-cd]pyrazol-6(2H)-one;1,9-Pyrazoloanthrone; Anthrapyrazolone) |
|---|---|
| 中文名稱 | 蒽[1,9-cd]吡唑-6(2H)-酮; 1,9-吡唑蒽酮; 吡唑并蒽酮 |
| CAS號 | 129-56-6 |
| 分子式 | C14H8N2O |
| 分子量 | 220.23 |
| MDL | MFCD00022289 |
| 英文名稱 | SP600125 (Synonyms: Nsc75890; SP 600125; Anthra[1,9-cd]pyrazol-6(2H)-one;1,9-Pyrazoloanthrone; Anthrapyrazolone) |
|---|---|
| 中文名稱 | 蒽[1,9-cd]吡唑-6(2H)-酮; 1,9-吡唑蒽酮; 吡唑并蒽酮 |
| CAS號 | 129-56-6 |
| 分子式 | C14H8N2O |
| 分子量 | 220.23 |
| MDL | MFCD00022289 |
SP600125 is an orally active, reversible, and ATP-competitive JNK inhibitor with IC50s of 40, 40 and 90 nM for JNK1, JNK2 and JNK3, respectively. SP600125 is a potent ferroptosis inhibitor. SP600125 induces the transformation of bladder cancer cells from autophagy to apoptosis.